At HormoneSynergy®, we try to be realistic, transparent, and honest with patients and customers. The real question is not whether aging happens. No hormone protocol stops time. Another experimental approach in healthy men featured suppression of endogenous testosterone production with a GnRH analogue, followed by treatment with different doses of weekly intramuscular testosterone esters for 20 weeks. Taken together, the epidemiological data suggest that a hypogonadal state promotes loss of muscle mass and a gain in fat mass, particularly visceral fat and therefore mimics the changes of ‘normal’ aging. In general terms, aging males are prone to loss of muscle mass and a gain in fat mass, especially in the form of visceral or central fat. The magnitude of this improvement is greater in the spine than in the hip and further studies are warranted to confirm or refute any differential effects of testosterone at these important sites. This could be due to the trials including patients who are not hypogonadal and being too short to allow for the maximal effects of testosterone. Men were eligible for the study if their serum total testosterone levels were less than 16.5 nmol/L, meaning that the study contained men who would usually be considered eugonadal. It is an important condition due to its prevalence and association with bone fractures; most commonly of the hip, vertebra and forearm. Other important factors include patient comorbidities and the preparation and route of testosterone replacement used in the study, which can affect the production of estrogen and dihydrotestosterone, testosterone’s active metabolites There is considerable heterogenicity in terms of study design and these differences have a potential to significantly affect the results seen in various studies. With advancing age there is also a reduction in androgen receptor concentration in some target tissues and this may contribute to the clinical syndrome of LOH (Ono et al 1988; Gallon et al 1989). Regular exercise, especially strength training and cardio, has been shown to naturally boost testosterone, improve muscle mass, and slow the aging process. In fact, researchers have found that men with exceptionally high testosterone levels don’t live longer than average—and may even have shorter lifespans. Simply boosting testosterone levels doesn’t stop the aging process—it just masks some of the symptoms temporarily. But starting around age 30, testosterone levels naturally begin to decline by about 1% per year. In men, testosterone is made mostly in the testicles and plays a central role in muscle mass, body hair, red blood cell production, and sperm development. For anyone exploring anti-aging peptides, the smartest path is to separate research from marketing, ask better questions, and work with medical professionals when health decisions are involved. The best injectable peptides for anti aging depend on what part of aging you are talking about. Interpretation of such data requires care, as the presentation of prostate cancer could be altered or delayed in patients with lower testosterone levels. Most longitudinal studies have not shown a correlation between testosterone levels and the future development of prostate cancer (Carter et al 1995; Heikkila et al 1999; Stattin et al 2004) but a recent study did find a positive association (Parsons et al 2005). Cross-sectional studies have not shown raised testosterone levels at the time of diagnosis of prostate cancer, and in fact, low testosterone at the time of diagnosis has been linked with more locally aggressive and malignant tumors (Massengill et al 2003; Imamoto et al 2005; Isom-Batz et al 2005). The question of whether testosterone treatment could cause new cases of prostate cancer, or more likely cause progression of undiagnosed histological prostate cancer that would otherwise have remained occult, is an important consideration when treating ageing males with testosterone. When you introduce testosterone from outside the body, the brain thinks it doesn’t need to make more. That’s why doctors monitor prostate-specific antigen (PSA) levels in men on TRT. In fact, the long-term effects on mortality remain unclear, and that’s a serious red flag when we’re talking about anti-aging strategies. No study has convincingly shown that testosterone therapy extends lifespan in older men. But in otherwise healthy older men with age-related declines, the benefits are often modest, inconsistent, or short-lived. In men with true testosterone deficiency, TRT can help improve some symptoms like low libido, depression, and muscle weakness. Clinics and online services offer easy access to testosterone therapy, often without proper testing or medical supervision.
